The National Biotechnology Research and Development Agency (NBRDA) has signed a Memorandum of Agreement (MoA) with China’s Shanghai Haiqi Industrial Company Ltd, to establish Nigeria’s first insulin production plant.
The agreement was formalised through a Memorandum of Agreement (MoA) signed in Abuja on Wednesday.
The facility is expected to reduce reliance on imported insulin and save billions of Naira in foreign exchange annually.
Prof. Abdullahi Mustapha, Director-General of NBRDA, signed on behalf of the Federal Government, while Shanghai Haiqi’s General Manager, Bokai Zhai, signed for the company.
According to Prof. Mustapha, the initiative marks a turning point for Nigeria’s health sector and biotechnology development.
The agreement signing was also witnessed by the Minister of Innovation, Science and Technology, Uche Nnaji.
“The National Biotechnology Research and Development Agency (NBRDA) entered into a partnership with a Chinese firm to establish Nigeria’s first insulin production plant.
“The move marks a major step toward Nigeria’s medical self-sufficiency, which is expected to save billions of naira in foreign exchange.
Search on Ojoojoo.com Nigeria's First Search Engine ...For More About This Post: Industry Sector Activities Slowed In August — CBN
While speaking, Nnaji highlighted the wider impact of the project, saying it will drive industrial innovation, reduce reliance on imports, and offer hope to families affected by diabetes.
Shanghai Haiqi Industrial Company’s General Manager, Bokai Zhai, added that the company is committed to transferring technology, building local capacity, and supporting the growth of Nigeria’s pharmaceutical industry.
The post Nigeria Signs Insulin Plant Deal With China’s Shanghai Haiqi appeared first on Channels Television.